SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-741748
Filing Date
2016-10-19
Accepted
2016-10-19 16:10:33
Documents
7
Period of Report
2016-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d273229d8k.htm 8-K 27940
2 EX-1.1 d273229dex11.htm EX-1.1 200316
3 EX-1.2 d273229dex12.htm EX-1.2 199119
4 EX-3.1 d273229dex31.htm EX-3.1 75230
5 EX-4.1 d273229dex41.htm EX-4.1 5822
6 EX-5.1 d273229dex51.htm EX-5.1 11098
7 GRAPHIC g273229snap0001.jpg GRAPHIC 3156
  Complete submission text file 0001193125-16-741748.txt   525460
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 161942689
SIC: 2834 Pharmaceutical Preparations